Adolescent cannabis consumption and schizophrenia: Epidemiological and experimental evidences

Adicciones

Volumn 22, Issue 3, 2010, Pages 185-190

  Parolaro, Daniela ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Adolescence; Brain; Cannabis; Psychosis; Schizophrenia

Indexed keywords

ADOLESCENT; ANIMAL; CANNABIS ADDICTION; EDITORIAL; HUMAN; SCHIZOPHRENIA;

ADOLESCENT; ANIMALS; HUMANS; MARIJUANA ABUSE; SCHIZOPHRENIA;

EID: 77955943966     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.178     Document Type: Article

References (28)

1. Piomelli D. The molecular logic of endocannabinoid signalling Nat Rev Neurosci 2003;4:873-84.
2. Harkany T, Mackie K. & Doherty P. Wiring and firing neuronal networks: endocannabinoids take center stage. Curr Opin Neurobiol 2008;18:338-45.
3. Berghuis SP, Dobszay MB, Wang X, Spano S., Ledda F, Sousa KM et al. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci U S A 2005;102:19115-20.
4. D'Souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/ schizophrenia: human studies. Eur Arch Psychiatry. Clin Neurosci 2009;259:413-31.
5. Sewell RA, Ranganathan M, D'Souza, DC. Cannabinoids and psychosis. Int Rev Psychiatry 2009;21:152-62.
6. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004;363:1579-88.
7. Ajdacic-Gross V, Lauber C, Warnke I, Haker H, Murray RM, Rossler W, Changing incidence of psychotic disorders among the young in Zurich. Schizophr Res 2007, 95:9-18.
8. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004;99:1333-41.
9. Schifman J, Nakamura B, Earleywine M, Labrie J Symptoms of schizotypy precede cannabis use. Psychiatry Res 2005;134:37-42.
10. Barkus E., Lewis S. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychol Med 2008;38:1267-76.
11. Sugranyes G, Flamarique I, Parellada E, Baeza I, Goti J, Fernández-Egea E, Bernardo M. Cannabis use and age of diagnosis of schizophrenia. Eur Psychiatry 2009;24:282-6.
12. Realini N, Rubino T, Parolaro D. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacological Research 2009;60:132-8.
13. Schneider M, Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 2003;28:1760-69.
14. Schneider, M, Koch M. The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion. Eur Neuropsychopharmacol 2007;17:180-6.
15. Vigano D, Guidali C, Petrosino S, Realini N, Rubino T, Di Marzo V, Parolaro D. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. Int J Neuropsychopharmacol 2009;12:599-614.
16. Guidali C, Viganò D, Petrosino S, Zamberletti E, Realini N, Binelli et al. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine. Int J Neuropsychopharmacol 2010 Mar. 3:1-12. [Epub ahead of print].
17. Malone DT, Jongenan D, Taylor DA. The effect of cannabidiol on open field behaviours induced by 9-tetrahydrocannabinol in rats. Pharmacol Biochem Behav 2009;93:91-6.
18. Malone DT, Taylor DA. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats. Behav Brain Res 2006;166:101-9.
19. Sciolino NR, Bortolato M, Eisenstein SA, Fu J, Oveisi F, Hohmann AG et al. Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats. Neuroscience 2010;168:371-86.
20. Rubino T, Realini, N, Braida D, Guidi S, Capurro V, Vigano D et al.. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 2009;8:763-72.
21. Rubino T, Realini, N, Braida D, Alberio T, Capurro V, Vigano D et al. The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotox Res 2009;15:291-302.
22. Suarez J, Llorente R, Romero-Zerbo SY, Mateos B, Bermudez-Silva F, De Fonseca F. R. et al. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB (1) and CB (2) cannabinoid receptors of neonatal rats. Hippocampus 2009;19:623-32.
23. Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y, et al. Brain Cannabinoid CB2 Receptor in Schizophrenia. Biol Psychiatry 2010;67:974-82.
24. Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuro Report 1999;10:1665-9.
25. Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol 2008;13:264-75.
26. Caspi A, Moffitt TE, Cannon M, Macclay J, Murray R, Harrington H et al. Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction. Biological Psychiatry 2005;57:1117-27.
27. Malone DT, Jongegan D, Taylor DA. The effect of cannabidiol on open field behaviours induced by 9-tetrahydrocannabinol in rats. Pharmacol Biochem Behav 2009;93:91-96.
28. Leweke FM, Schneider U, Radwan M, Schmidt E, Emrich HM. Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav 2000;66:175-81.